Last reviewed · How we verify

NCT03436537

Development and Validation of the Periodontal Aesthetic Perception Scale in Patients With Periodontal Problems

Completed Last updated 19 February 2018
What this trial tests

trial testing Periodontal Aesthetic Perception Scale in Gingival Enlargement in 100 participants. Completed in 1 December 2017.

Timeline
2 January 2017
Primary endpoint
1 July 2017
1 December 2017

Quick facts

Lead sponsorTokat Gaziosmanpasa University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date2 January 2017
Primary completion1 July 2017
Estimated completion1 December 2017
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Tokat Gaziosmanpasa University

Who can join

Adults 18 to 65, any sex, with Gingival Enlargement or Gingival Recession. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aesthetics for individuals become increasingly important, while the aesthetic effects of periodontal disease is an important issue that should be assessed by the patient's perception. The results demonstrate that the periodontal aesthetic perception scale showed reliable and valid scores in healthy controls and periodontal patients. The periodontal aesthetic perception scale may be an appropriate tool to assess periodontal esthetic in clinical and research settings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gingival Enlargement

Currently open trials in the same condition.

Other Tokat Gaziosmanpasa University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03436537.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing